Project Grant HT94252510344
Award Date
9/30/25
Completion Date
9/29/27
Dollars Obligated
$505K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
New York, NY 10029, USA
Similar Awards
The Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $507,000 Project Grant to the Icahn School of Medicine at Mount Sinai. The grant, effective from Sep 1, 2025 to Aug 31, 2027, will support research to investigate tumor-intrinsic epigenetic mechanisms modulating antitumor immune responses in metastatic prostate cancer. As a leading academic medical center, the Icahn School of Medicine at Mount Sinai has a strong track record of...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $633,750.00 to the Icahn School of Medicine at Mount Sinai to study the "Interplay Between Sensory Neurons and NK Cells During Breast Cancer Metastatic Dormancy." The 3-year award, running from August 1, 2025 to July 31, 2028, will support advanced biomedical research to transform healthcare for military service members, veterans, and the...
This federal Project Grant award of $2,028,000.00, awarded on April 1, 2025 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research aimed at identifying epigenetically driven vulnerabilities in metastatic castration-resistant prostate cancer. The award was granted to the Icahn School of Medicine at Mount Sinai, a prominent academic medical center and research institution in New York City. Through this...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) is providing $1,014,000.00 to the Icahn School of Medicine at Mount Sinai to conduct research aimed at creating cures for patients with Langerhans cell histiocytosis. The research, which is scheduled to take place from September 1, 2024 to August 31, 2028, will leverage the institution's expertise in areas such as cancer biology, immunology, and clinical...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,227,478 project grant to the Icahn School of Medicine at Mount Sinai. The 3-year grant, which runs from July 1, 2025 to June 30, 2028, will support research to develop biomarkers that can help refine an individualized, risk-adapted approach to bladder-sparing treatment for muscle-invasive bladder cancer. As a leading academic medical center, the Icahn School of Medicine at Mount Sinai has a...
The Defense Health Agency has awarded a $766,079 Project Grant to the Icahn School of Medicine at Mount Sinai to conduct research under the Military Medical Research and Development program (CFDA 12.420). The grant, which runs from September 1, 2023 to August 31, 2026, aims to "UNRAVEL THE EVOLUTION OF MELANOMA WITHIN THE HOST IMMUNE ECOSYSTEM." As a leading private medical research institution, the Icahn School of Medicine at Mount Sinai has a history of providing a wide range of...
This federal Project Grant award of $2,175,896.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the Icahn School of Medicine at Mount Sinai. The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public, with a specific focus on understanding the metabolites, metabolic pathways, and risk of Crohn's disease. The project will be conducted at the...
The Icahn School of Medicine at Mount Sinai has been awarded a $591,486 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). This 3-year grant, running from September 1, 2023 to August 31, 2026, will support the development of a novel immuno-oncology pipeline for FGFR2 fusion-positive cholangiocarcinoma. The funding will enable the medical school to conduct research aimed at transforming health care for service members and the...
This federal Project Grant award of $633,750.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award supports advanced biomedical research at the Icahn School of Medicine at Mount Sinai (ISMMS) in New York, NY, aimed at understanding the interplay between sensory neurons and natural killer (NK) cells during breast cancer metastatic dormancy. This 3-year research project, from August 1, 2025 to July 31, 2028, seeks to...
This $507,000 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) is supporting research at the Icahn School of Medicine at Mount Sinai (ISMMS) to study the role of exosomes in promoting prostate cancer metastasis and resistance to androgen deprivation therapy. The 2-year grant, awarded on June 15, 2024, will enable ISMMS to conduct innovative biomedical research with the goal of advancing understanding and treatment of...